These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34371284)
21. Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1. Deng M; He W; Tan Y; Han H; Hu X; Xia K; Zhang Z; Yan R J Biol Chem; 2013 Oct; 288(42):30236-30245. PubMed ID: 24005676 [TBL] [Abstract][Full Text] [Related]
22. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease. Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908 [TBL] [Abstract][Full Text] [Related]
23. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus. Sanchez-Varo R; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; De Castro V; Jimenez S; Ruano D; Vizuete M; Davila JC; Garcia-Verdugo JM; Jimenez AJ; Vitorica J; Gutierrez A Acta Neuropathol; 2012 Jan; 123(1):53-70. PubMed ID: 22020633 [TBL] [Abstract][Full Text] [Related]
24. Identification of rare RTN3 variants in Alzheimer's disease in Han Chinese. Zou Y; He W; Wang K; Han H; Xiao T; Chen X; Zhou B; Tan J; Xia K; Tang B; Chen C; Shen L; Yan R; Zhang Z Hum Genet; 2018 Feb; 137(2):141-150. PubMed ID: 29356939 [TBL] [Abstract][Full Text] [Related]
25. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Dickson TC; King CE; McCormack GH; Vickers JC Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781 [TBL] [Abstract][Full Text] [Related]
26. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. Abad MA; Enguita M; DeGregorio-Rocasolano N; Ferrer I; Trullas R J Neurosci; 2006 Dec; 26(49):12735-47. PubMed ID: 17151277 [TBL] [Abstract][Full Text] [Related]
27. Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress. Zhao B; Pan BS; Shen SW; Sun X; Hou ZZ; Yan R; Sun FY J Biol Chem; 2013 May; 288(22):15590-9. PubMed ID: 23592790 [TBL] [Abstract][Full Text] [Related]
28. Use of YFP to study amyloid-beta associated neurite alterations in live brain slices. Brendza RP; Simmons K; Bales KR; Paul SM; Goldberg MP; Holtzman DM Neurobiol Aging; 2003 Dec; 24(8):1071-7. PubMed ID: 14643378 [TBL] [Abstract][Full Text] [Related]
29. Reticulon 3 mediates Bcl-2 accumulation in mitochondria in response to endoplasmic reticulum stress. Wan Q; Kuang E; Dong W; Zhou S; Xu H; Qi Y; Liu Y Apoptosis; 2007 Feb; 12(2):319-28. PubMed ID: 17191123 [TBL] [Abstract][Full Text] [Related]
30. Reticulon 3 regulates very low density lipoprotein secretion by controlling very low density lipoprotein transport vesicle biogenesis. Siddiqi S; Zhelyabovska O; Siddiqi SA Can J Physiol Pharmacol; 2018 Jul; 96(7):668-675. PubMed ID: 29756473 [TBL] [Abstract][Full Text] [Related]
31. α-secretase cleaved amyloid precursor protein (APP) accumulates in cholinergic dystrophic neurites in normal, aged hippocampus. Yoon SY; Choi JU; Cho MH; Yang KM; Ha H; Chung IJ; Cho GS; Kim DH Neuropathol Appl Neurobiol; 2013 Dec; 39(7):800-16. PubMed ID: 23414335 [TBL] [Abstract][Full Text] [Related]
34. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models. Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603 [TBL] [Abstract][Full Text] [Related]
35. Reticulon 3 attenuates the clearance of cytosolic prion aggregates via inhibiting autophagy. Chen R; Jin R; Wu L; Ye X; Yang Y; Luo K; Wang W; Wu D; Ye X; Huang L; Huang T; Xiao G Autophagy; 2011 Feb; 7(2):205-16. PubMed ID: 21119307 [TBL] [Abstract][Full Text] [Related]
37. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains. Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764 [TBL] [Abstract][Full Text] [Related]
38. Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis. Sadleir KR; Popovic J; Khatri A; Vassar R PLoS One; 2022; 17(2):e0263332. PubMed ID: 35108319 [TBL] [Abstract][Full Text] [Related]
39. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Su JH; Cummings BJ; Cotman CW Acta Neuropathol; 1998 Nov; 96(5):463-71. PubMed ID: 9829809 [TBL] [Abstract][Full Text] [Related]
40. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease. Dickson TC; Saunders HL; Vickers JC Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]